Editorial
Accepted on 08 Apr 2025
Editorial: Emerging Trends in Real-World Pharmacoepidemiology
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1601477
Type at least 3 characters
442 articles
Original Research
Accepted on 08 Apr 2025
Acute Liver Injury and Diffuse subcutaneous pneumatosis Following Compound paracetamol and Amantadine hydrochloride tablets Poisoning: A Case Report
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1503449
Original Research
Accepted on 08 Apr 2025
Post-marketing safety concerns with pirfenidone and nintedanib: An analysis of individual case safety reports from the FDA adverse event reporting system (FAERS) database and the Japanese Adverse Drug Event Report (JADER) databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1530697
Original Research
Accepted on 08 Apr 2025
Real-World Pharmacovigilance Analysis of Drug-Related Cataracts Using the FDA Adverse Event Reporting System Database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1498191
Systematic Review
Accepted on 07 Apr 2025
Evaluating the Efficacy of Valproic Acid in Alcohol Use Disorders: A Systematic Analysis of Clinical Trials from ClinicalTrials.gov
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1503035
Correction
Published on 07 Apr 2025
Corrigendum: Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586073
Original Research
Accepted on 04 Apr 2025
Drug-induced pancreatitis: a real-world analysis of the FDA Adverse Event Reporting System and network pharmacology
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564127
Original Research
Published on 04 Apr 2025
Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1394458
- 234 views
Original Research
Accepted on 02 Apr 2025
Charting the COVID-19 Vaccination Journey in Saudi Arabia: Insights into Post-Vaccination Adverse Effects and Immunization Dynamics
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561410
Original Research
Accepted on 28 Mar 2025
Association of long-term use of dipeptidyl peptidase-4 inhibitors with the risk of diabetic retinopathy in patients with diabetes mellitus: A real-world evidence study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1518545
Original Research
Published on 26 Mar 2025
Drug-induced herpes zoster: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565480
- 429 views
Original Research
Published on 26 Mar 2025
Community pharmacists’ views towards implementing a patient self-administered screening tool designed to identify risk of medication-related problems
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1531500
- 430 views
Original Research
Accepted on 25 Mar 2025
A real-world pharmacovigilance study of efgartigimod alfa in the FDA Adverse Event Reporting System database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510992
- 288 views
Original Research
Published on 20 Mar 2025
The interaction between a leflunomide-response methylation site (cg17330251) and variant (rs705379) on response to leflunomide in patients with rheumatoid arthritis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1499723
- 358 views
Original Research
Accepted on 18 Mar 2025
Application of Global Trigger Tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1514942
Systematic Review
Published on 18 Mar 2025
Correlation between UGT1A1 polymorphism and efficacy and toxicity of irinotecan in Chinese cancer patients
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563566
- 378 views